Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Utilizing Fcepsilon-Bak chimeric protein for studying IgE-FcepsilonRI interactions.

Ruth Belostotsky1, Haya Lorberboum-Galski

  • 1Department of Cellular Biochemistry and Human Genetics, Hadassah Medical School, Hebrew University, 91120 Jerusalem, Israel.

Clinical Immunology (Orlando, Fla.)
|February 14, 2004
PubMed
Summary

Engineered Fcepsilon-Bak protein triggers apoptosis in mast cells by binding to the IgE high affinity receptor (FcepsilonRI). This shows promise for antiallergic therapies and confirms cross-species receptor interaction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rescue of the First Mitochondrial Membrane Carrier, the mPiC, by TAT-Mediated Protein Replacement Treatment.

International journal of molecular sciences·2025
Same author

Inducing Targeted, Caspase-Independent Apoptosis with New Chimeric Proteins for Treatment of Solid Cancers.

Cancers·2025
Same author

Letter in response to case "Variants in the SARS2 gene cause HUPRA syndrome with atypical features: two case reports and review of the literature.

Oxford medical case reports·2024
Same author

The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver-Serum-Brain Response.

Cells·2023
Same author

Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment.

Cancers·2023
Same author

Catabolism of Hydroxyproline in Vertebrates: Physiology, Evolution, Genetic Diseases and New siRNA Approach for Treatment.

International journal of molecular sciences·2022

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • A pro-apoptotic Fcepsilon-Bak chimeric protein was developed to target cells expressing the IgE high affinity receptor (FcepsilonRI).
  • Previous studies showed this protein is internalized by mast cells and induces apoptosis, suggesting potential for antiallergic therapy.

Purpose of the Study:

  • To investigate the endocytosis of monomeric Fcepsilon-Bak-FcepsilonRI complexes.
  • To determine if the human IgE (Fcepsilon) binding domain interacts with rodent FcepsilonRI.
  • To elucidate the mechanisms underlying Fcepsilon-Bak-mediated cell death.

Main Methods:

  • Utilized established rodent and human cell cultures.
  • Employed primary mouse mast cell cultures.
  • Investigated the interaction of human and mouse Fcepsilon-Bak with FcepsilonRI-positive cells.

Related Experiment Videos

Main Results:

  • Fcepsilon-Bak binding to the cell membrane is followed by rapid endocytosis and apoptosis of target cells.
  • The interaction is dependent on FcepsilonRI, not other IgE receptors.
  • Cellular effects are influenced by FcepsilonRI expression levels but not cell origin or Fcepsilon source.
  • Human IgE Fc fragment interacts with both human and rodent FcepsilonRI.

Conclusions:

  • Monomeric Fcepsilon-Bak-FcepsilonRI complexes undergo endocytosis due to the chimeric protein's inability to transduce signals.
  • The variable portion of IgE is not required for Fcepsilon-Bak-mediated apoptosis.
  • Fcepsilon-Bak demonstrates potential for antiallergic therapy through targeted mast cell apoptosis.